Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT05694273
Starting soon Observational

Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation

NCT05694273 · tracked via the Priya Life Science China tracker
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
Observational
Started
2025-01-15
Last updated
2024-04-04

Condition(s) studied

ArrhythmiaAcute Cerebrovascular Disease

Study summary

This study aims to evaluate the incidence, clinical characteristics, and short-term prognosis of acute cerebrovascular events occurring in-hospital in patients with arrhythmias following catheter ablation. The goal is to provide evidence supporting the improvement of patient quality of life and reduction of in-hospital acute cerebrovascular complications in patients with post-ablation arrhythmias. This will also contribute to the evidence-based clinical management of such patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * 1.Patients who undergo catheter ablation for arrhythmias. Exclusion Criteria: * 1\. Patients were diagnosed of acute cerebrovascular disease prior to radiofrequency catheter ablation; * 2\. Patients \< 18 years or \> 80 years; * 3\. Patients with uncomplete clinical data.

Primary outcome measure(s)

  • Incidence of MACCE — 3 months after enrollment
    Major adverse cardiovascular and cerebrovascular events, a composite of all-cause mortality, myocardial infarction and stroke. The data will be obtained at 3-month follow-up, according to medical records of all patients.

Trial sites (1)

FacilityCityRegionStatus
First Affiliated Hospital of Xian Jiantong University Xi'an Shaanxi

More First Affiliated Hospital Xi'an Jiaotong University trials in China

Risk Stratification and Early Prevention Strategies for Non-compaction of Ventricular Myocardium (CAPTAIN) Starting soon
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients Recruiting
Peripheral Blood Lipidomic and Ceramide Profiles in Atrial Fibrillation Recruiting
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias Starting soon
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy Recruiting

Other trials for the same condition

Arrhythmia Cohort Study Starting soon
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting Recruiting
Deep Learning for Intelligent Identification of Arrhythmias Starting soon
Electrophysiological Outcomes After Transcatheter Aortic Valve Replacement Active, not recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05694273 on ClinicalTrials.gov ↗ ← All trials in China